SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001033427-18-000044
Filing Date
2018-11-07
Accepted
2018-11-07 09:07:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 eaglepharm13ga110312018.htm SC 13G/A 69331
  Complete submission text file 0001033427-18-000044.txt   70908
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88022 | Film No.: 181164886
SIC: 2834 Pharmaceutical Preparations

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST ROAD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

IRS No.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A